- Oops!Something went wrong.Please try again later.
Shares of Co-Diagnostics (NASDAQ: CODX) were running 4.6% higher Tuesday morning as of 10:30 a.m. ET on no company-specific news, though it may be getting a boost from an update from the World Health Organization (WHO). The World Health Organization reported this morning there are 5,322 laboratory-confirmed cases of monkeypox. Co-Diagnostics CEO Dwight Egan has said the healthcare company was founded to make low-cost, high-quality tests available wherever they're needed, and it looks "forward to eventually making this test available in affected regions as needed to help slow the spread of the virus through early and accurate detection."